Form D · Biotechnology

Cellular Biomedicine Group, Inc.

Cupertino, CA · CIK 0001378624

Offering snapshot reported Feb 2, 2018 · SEC filing

Reported sold
$30.6M
Offering amount: $30.6M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 30, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 2, 2018Initial$30,600,000No comparison3SEC filing
Apr 11, 2014Initial$6,907,995No comparison12SEC filing
Jul 26, 2013Initial$3,005,006No comparison10SEC filing
Jun 25, 2013Initial$0No comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-304709

Source: Form D, filed Feb 2, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chun Kwok Alan Au Director
Jeff Auerbach Director
Terry A. Belmont Director, Executive
David Bolocan Director
Wei (William) Cao Director, Executive
Andrew Chan Executive
Jainping Dai Director
Jianping Dai Director
Gerardus A. Hoogland Director
Gang Ji Director
Norman Klein Director
Tony Liu Director
Bizou (Tony) Liu Director
Wen (Steve) Tao Liu Director
Tony (Bizuo) Liu Executive
Wen Tao (Steve) Liu Director
Nadir Patel Director
Keith Wong Director
Yihong Yao Executive
Hansheng Zou Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
19925 Stevens Creek Blvd., Suite 100
Cupertino, CA, 95014